BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38525512)

  • 1. Prognostic factors and real-life applicability of prognostic models for patients with bone metastases of carcinoma.
    Dalkir KA; Mirioglu A; Kundakci B; Bagir M; Deveci MA; Ozberlas HS
    Acta Orthop Traumatol Turc; 2024 Jan; 58(1):62-67. PubMed ID: 38525512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?
    Pan YT; Lin YP; Yen HK; Yen HH; Huang CC; Hsieh HC; Janssen S; Hu MH; Lin WH; Groot OQ
    Clin Orthop Relat Res; 2024 Mar; ():. PubMed ID: 38517402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020.
    de Groot TM; Ramsey D; Groot OQ; Fourman M; Karhade AV; Twining PK; Berner EA; Fenn BP; Collins AK; Raskin K; Lozano S; Newman E; Ferrone M; Doornberg JN; Schwab JH
    Clin Orthop Relat Res; 2023 Dec; 481(12):2419-2430. PubMed ID: 37229565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.
    Anderson AB; Wedin R; Fabbri N; Boland P; Healey J; Forsberg JA
    Clin Orthop Relat Res; 2020 Apr; 478(4):808-818. PubMed ID: 32195761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.
    Huang CC; Peng KP; Hsieh HC; Groot OQ; Yen HK; Tsai CC; Karhade AV; Lin YP; Kao YT; Yang JJ; Dai SH; Huang CC; Chen CW; Yen MH; Xiao FR; Lin WH; Verlaan JJ; Schwab JH; Hsu FM; Wong T; Yang RS; Yang SH; Hu MH
    Clin Orthop Relat Res; 2023 Jun; 482(1):143-57. PubMed ID: 37306629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
    Tseng TE; Lee CC; Yen HK; Groot OQ; Hou CH; Lin SY; Bongers MER; Hu MH; Karhade AV; Ko JC; Lai YH; Yang JJ; Verlaan JJ; Yang RS; Schwab JH; Lin WH
    Clin Orthop Relat Res; 2022 Feb; 480(2):367-378. PubMed ID: 34491920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of survival prediction models for bone metastases of the extremities following surgery.
    Park JH; Won J; Kim HS; Kim Y; Kim S; Han I
    Bone Joint J; 2024 Feb; 106-B(2):203-211. PubMed ID: 38295850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
    Sørensen MS; Gerds TA; Hindsø K; Petersen MM
    Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates?
    Janssen SJ; van der Heijden AS; van Dijke M; Ready JE; Raskin KA; Ferrone ML; Hornicek FJ; Schwab JH
    Clin Orthop Relat Res; 2015 Oct; 473(10):3112-21. PubMed ID: 26155769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the survival of patients with bone metastases treated with radiation therapy: a validation study of the Katagiri scoring system.
    Kubota H; Soejima T; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Tsujino K; Fujita I; Fujimoto T; Morishita M; Ikegaki J; Matsumoto K; Sasaki R
    Radiat Oncol; 2019 Jan; 14(1):13. PubMed ID: 30658673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases.
    Errani C; Cosentino M; Ciani G; Ferra L; Alfaro PA; Bordini B; Donati DM
    Int Orthop; 2021 May; 45(5):1337-1346. PubMed ID: 33392682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?
    Ogura K; Gokita T; Shinoda Y; Kawano H; Takagi T; Ae K; Kawai A; Wedin R; Forsberg JA
    Clin Orthop Relat Res; 2017 Sep; 475(9):2263-2270. PubMed ID: 28560532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the SORG Orthopaedic Research Group Hip Fracture Delirium Algorithm Perform Well on an Independent Intercontinental Cohort of Patients With Hip Fractures Who Are 60 Years or Older?
    Oosterhoff JHF; Oberai T; Karhade AV; Doornberg JN; Kerkhoffs GMMJ; Jaarsma RL; Schwab JH; Heng M
    Clin Orthop Relat Res; 2022 Nov; 480(11):2205-2213. PubMed ID: 35561268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of lab data and performance comparison by validating survival prediction models for patients with spinal metastases after radiotherapy.
    Yen HK; Hu MH; Zijlstra H; Groot OQ; Hsieh HC; Yang JJ; Karhade AV; Chen PC; Chen YH; Huang PH; Chen YH; Xiao FR; Verlaan JJ; Schwab JH; Yang RS; Yang SH; Lin WH; Hsu FM
    Radiother Oncol; 2022 Oct; 175():159-166. PubMed ID: 36067909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of survival after surgical management of femoral metastatic bone disease - A comparison of prognostic models.
    Meares C; Badran A; Dewar D
    J Bone Oncol; 2019 Apr; 15():100225. PubMed ID: 30847272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
    Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
    Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of scoring systems and prognostic factors in patients with spinal metastases from nasopharyngeal carcinoma.
    Kumar N; Tan JJ; Zaw AS; Lim JL; Wai KL; Malhotra R; Loh TK; Liu GK; Thambiah J
    Spine J; 2014 Dec; 14(12):2946-53. PubMed ID: 24912121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Prognostication in Patients with Skeletal Metastases from Nasopharyngeal Carcinoma: An Evaluation of the Scandinavian Sarcoma Group, Katagiri and Bauer Scoring Systems.
    Tan JJ; Zaw AS; Malhotra R; Wai KL; Tan JY; Kumar N
    Ann Acad Med Singap; 2016 Feb; 45(2):51-60. PubMed ID: 27125346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor mutations should be considered as a prognostic factor for survival of patients with pathological fractures or painful bone metastases from non-small cell lung cancer.
    Willeumier JJ; van der Hoeven NM; Bollen L; Willems LN; Fiocco M; van der Linden YM; Dijkstra PD
    Bone Joint J; 2017 Apr; 99-B(4):516-521. PubMed ID: 28385942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.